The Food and Drug Administration today announced a voluntary pilot program to expedite approvals of certain changes to ethylene oxide sterilization processes and facilities. Under the pilot program, facilities that use fixed-chamber ethylene oxide sterilization processes to sterilize single-use medical devices would submit a “master file” to the FDA when making certain changes to their location or changes to their sterilization processes that use lower ethylene oxide concentrations. The FDA believes the program will allow more efficient review and feedback, ultimately allowing the agency to provide a more nimble response to site closures in the future. In addition, FDA said it will work with 12 applicants to its innovation challenges to accelerate the development and review of innovative technologies for sterilization processes, and is moving forward with certain recommendations from its recent advisory committee meeting.

Related News Articles

Headline
The Food and Drug Administration today reported 55 injuries and one death involving an infusion pump and vital signs monitoring system. Becton Dickinson…
Chairperson's File
America’s health care providers are no strangers to challenges. Time and again, we have overcome complex, difficult and daunting situations by using innovative…
#HealthCareInnovation Thursday Blog
At the AHA and AHA Center for Health Innovation, we’re working with hospitals and health systems and their community partners to build a culture of…
Headline
Researchers and others may apply through April 6 to participate in a $175,000 competition to develop innovative digital solutions to help manage the…
#HealthCareInnovation Thursday Blog
The most important thing startups bring to health care innovation may not be what you think — it’s how you think. Down the street from the epicenter of the…
#HealthCareInnovation Thursday Blog
At this year’s J.P. Morgan Healthcare Conference in San Francisco, nearly 30 health systems — among more than 450 companies represented at the conference —…